Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales
Yahoo/Zacks.com
Friday, August 8, 2014 - 11:40am
tags:
Vivus, earnings
Biosimilar preclinical demand growing as US market beckons, says Harlan
Biopharma-Reporter
Friday, August 8, 2014 - 9:34am
tags:
biosimilars, Sandoz, Novartis, FDA
Fujifilm Drug Eyed As Possible Treatment for Ebola Virus
WSJ Online
Friday, August 8, 2014 - 9:12am
tags:
ebola virus, Fujifilm, favipiravir, Toyama Chemical Co.
Roche Rebuked by U.K. on $152,850 Breast Cancer Drug
Bloomberg
Friday, August 8, 2014 - 8:44am
tags:
UK, Roche, breast cancer, Kadcyla
Nicox to co-promote eye drug with Bausch + Lomb in the US
Yahoo/Reuters
Friday, August 8, 2014 - 8:43am
tags:
NicOx, Bausch & Lomb, Valeant Pharmaceuticals, latanoprostene
Ebola Drug Firm Shares Go Bonkers After FDA Announcement
Yahoo/Business Insider
Friday, August 8, 2014 - 8:42am
tags:
FDA, Tekmira Pharmaceuticals, TKM-EBOLA
[video] Glaxo trial begins in China
CNBC
Friday, August 8, 2014 - 8:39am
tags:
China, GSK
Even At $900 (Vs. $84,000 In US) Hep C Cure Sovaldi's Cost Could Be Unacceptable In India
Forbes
Friday, August 8, 2014 - 8:36am
tags:
India, Sovaldi, drug pricing, hepatitis C
Biotech firm Galapagos says GSK stops joint drug project
Yahoo/Reuters
Friday, August 8, 2014 - 8:36am
tags:
GSK, Galapagos, GSK2586184, ulcerative colitis
Pfizer confronts surge of lawsuits over Lipitor
Yahoo/Reuters
Friday, August 8, 2014 - 8:34am
tags:
Pfizer, Lipitor, diabetes
Most popular news headlines for Thursday, August 7 2014
CP Wire
Friday, August 8, 2014 - 8:14am
tags:
Allergan, M&A, Valeant Pharmaceuticals, tax inversions, PTC Therapeutics, Duchenne Muscular Dystrophy, ebola virus, Tekmira Pharmaceuticals
Vascular Biogenics ($VBLX) trading halted, will IPO be reversed?
CP Wire
Thursday, August 7, 2014 - 6:19pm
tags:
IPOs, Vascular Biogenics
UPDATED: Ebola drug developer Tekmira trading halted after volatile trading day, then gets potential big news from FDA
CP Wire
Thursday, August 7, 2014 - 5:07pm
tags:
Tekmira Pharmaceuticals, FDA, ebola virus
Takeda to Extend Global Reach
Drug Discovery and Development
Thursday, August 7, 2014 - 4:38pm
tags:
Takeda
Pharma shares sink as U.S. threatens tax-inversion crackdown
Fierce Pharma
Thursday, August 7, 2014 - 2:36pm
tags:
tax inversions, M&A, US Treasury
Is Durata's Antibiotic Overpriced? A Twitter Conversation
Forbes
Thursday, August 7, 2014 - 2:33pm
tags:
Durata Therapeutics, antibiotics, twitter, social media, Dalvance, The Medicines Company, oritavancin
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales
Yahoo/Zacks.com
Thursday, August 7, 2014 - 2:24pm
tags:
earnings, NPS Pharmaceuticals
Ligand Gains on Q2 Earnings Beat, Increases Guidance
Yahoo/Zacks.com
Thursday, August 7, 2014 - 2:23pm
tags:
earnings, Ligand Pharmaceuticals
Device maker, drug company plunge by double digits on weak earnings
Marketwatch
Thursday, August 7, 2014 - 2:18pm
tags:
devices, earnings, Durata Therapeutics, Thoratec
Dealpolitik: Did Valeant Make a Strategic Error in Its Allergan Bid?
WSJ Online
Thursday, August 7, 2014 - 9:58am
tags:
Valeant Pharmaceuticals, Allergan, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.